 | • レポートコード：GIR-107A12590 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ポイントオブケア感染症診断・検査のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ポイントオブケア感染症診断・検査の種類別市場規模（HIV POC、クロストリジウム・ディフィシルPOC、HBV POC、肺炎・ストレプトコッカス関連感染症、呼吸器合胞体ウイルス（RSV）POC、HPV POC、インフルエンザ/インフルエンザPOC、その他）、用途別市場規模（病院、クリニック、在宅、生活支援医療施設、研究所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ポイントオブケア感染症診断・検査の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbott、Thermo Fisher Scientific Inc、Roche、Siemens Healthineers、BD & Company、Chembio Diagnostics Inc.、Trinity Biotech、Cardinal Health、Quest Diagnostics Inc.、Bio-Rad Labs Inc.、bioMérieux SA、Sight Diagnostics Ltd.、Gene POC、Trivitron Healthcare、OJ-Bio Ltd.、Ortho-Clinical Diagnostics ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：HIV POC、クロストリジウム・ディフィシルPOC、HBV POC、肺炎・ストレプトコッカス関連感染症、呼吸器合胞体ウイルス（RSV）POC、HPV POC、インフルエンザ/インフルエンザPOC、その他 ・用途別分析2016年-2026年：病院、クリニック、在宅、生活支援医療施設、研究所、その他 ・ポイントオブケア感染症診断・検査の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ポイントオブケア感染症診断・検査のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ポイントオブケア感染症診断・検査のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ポイントオブケア感染症診断・検査の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ポイントオブケア感染症診断・検査の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Point-of-Care Infectious Disease Diagnostics & Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Point-of-Care Infectious Disease Diagnostics & Testing size is estimated to be USD 1289.9 million in 2026 from USD 1054.5 million in 2020, with a change XX% between 2020 and 2021. The global Point-of-Care Infectious Disease Diagnostics & Testing market size is expected to grow at a CAGR of 5.2% for the next five years.
Market segmentation
Point-of-Care Infectious Disease Diagnostics & Testing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
Other Infectious Disease POC
Market segment by Application, can be divided into
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others
Market segment by players, this report covers
Abbott
Thermo Fisher Scientific Inc
Roche
Siemens Healthineers
BD & Company
Chembio Diagnostics Inc.
Trinity Biotech
Cardinal Health
Quest Diagnostics Inc.
Bio-Rad Labs Inc.
bioMérieux SA
Sight Diagnostics Ltd.
Gene POC
Trivitron Healthcare
OJ-Bio Ltd.
Ortho-Clinical Diagnostics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Point-of-Care Infectious Disease Diagnostics & Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Point-of-Care Infectious Disease Diagnostics & Testing, with revenue, gross margin and global market share of Point-of-Care Infectious Disease Diagnostics & Testing from 2019 to 2021.
Chapter 3, the Point-of-Care Infectious Disease Diagnostics & Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Point-of-Care Infectious Disease Diagnostics & Testing market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Point-of-Care Infectious Disease Diagnostics & Testing research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Point-of-Care Infectious Disease Diagnostics & Testing
1.2 Classification of Point-of-Care Infectious Disease Diagnostics & Testing by Type
1.2.1 Overview: Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Type in 2020
1.2.3 HIV POC
1.2.4 Clostridium difficile POC
1.2.5 HBV POC
1.2.6 Pneumonia or Streptococcus associated infections
1.2.7 Respiratory syncytial virus (RSV) POC
1.2.8 HPV POC
1.2.9 Influenza/Flu POC
1.2.10 Other Infectious Disease POC
1.3 Global Point-of-Care Infectious Disease Diagnostics & Testing Market by Application
1.3.1 Overview: Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home
1.3.5 Assisted Living Healthcare Facilities
1.3.6 Laboratories
1.3.7 Others
1.4 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size & Forecast
1.5 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast by Region
1.5.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region, (2016-2021)
1.5.3 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Prospect (2016-2026)
1.5.4 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Prospect (2016-2026)
1.5.6 South America Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Point-of-Care Infectious Disease Diagnostics & Testing Market Drivers
1.6.2 Point-of-Care Infectious Disease Diagnostics & Testing Market Restraints
1.6.3 Point-of-Care Infectious Disease Diagnostics & Testing Trends Analysis
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.1.4 Abbott Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott Recent Developments and Future Plans
2.2 Thermo Fisher Scientific Inc
2.2.1 Thermo Fisher Scientific Inc Details
2.2.2 Thermo Fisher Scientific Inc Major Business
2.2.3 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.2.4 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Thermo Fisher Scientific Inc Recent Developments and Future Plans
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.3.4 Roche Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Roche Recent Developments and Future Plans
2.4 Siemens Healthineers
2.4.1 Siemens Healthineers Details
2.4.2 Siemens Healthineers Major Business
2.4.3 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.4.4 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Siemens Healthineers Recent Developments and Future Plans
2.5 BD & Company
2.5.1 BD & Company Details
2.5.2 BD & Company Major Business
2.5.3 BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.5.4 BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 BD & Company Recent Developments and Future Plans
2.6 Chembio Diagnostics Inc.
2.6.1 Chembio Diagnostics Inc. Details
2.6.2 Chembio Diagnostics Inc. Major Business
2.6.3 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.6.4 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Chembio Diagnostics Inc. Recent Developments and Future Plans
2.7 Trinity Biotech
2.7.1 Trinity Biotech Details
2.7.2 Trinity Biotech Major Business
2.7.3 Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.7.4 Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Trinity Biotech Recent Developments and Future Plans
2.8 Cardinal Health
2.8.1 Cardinal Health Details
2.8.2 Cardinal Health Major Business
2.8.3 Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.8.4 Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Cardinal Health Recent Developments and Future Plans
2.9 Quest Diagnostics Inc.
2.9.1 Quest Diagnostics Inc. Details
2.9.2 Quest Diagnostics Inc. Major Business
2.9.3 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.9.4 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Quest Diagnostics Inc. Recent Developments and Future Plans
2.10 Bio-Rad Labs Inc.
2.10.1 Bio-Rad Labs Inc. Details
2.10.2 Bio-Rad Labs Inc. Major Business
2.10.3 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.10.4 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Bio-Rad Labs Inc. Recent Developments and Future Plans
2.11 bioMérieux SA
2.11.1 bioMérieux SA Details
2.11.2 bioMérieux SA Major Business
2.11.3 bioMérieux SA Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.11.4 bioMérieux SA Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 bioMérieux SA Recent Developments and Future Plans
2.12 Sight Diagnostics Ltd.
2.12.1 Sight Diagnostics Ltd. Details
2.12.2 Sight Diagnostics Ltd. Major Business
2.12.3 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.12.4 Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Sight Diagnostics Ltd. Recent Developments and Future Plans
2.13 Gene POC
2.13.1 Gene POC Details
2.13.2 Gene POC Major Business
2.13.3 Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.13.4 Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Gene POC Recent Developments and Future Plans
2.14 Trivitron Healthcare
2.14.1 Trivitron Healthcare Details
2.14.2 Trivitron Healthcare Major Business
2.14.3 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.14.4 Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Trivitron Healthcare Recent Developments and Future Plans
2.15 OJ-Bio Ltd.
2.15.1 OJ-Bio Ltd. Details
2.15.2 OJ-Bio Ltd. Major Business
2.15.3 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.15.4 OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 OJ-Bio Ltd. Recent Developments and Future Plans
2.16 Ortho-Clinical Diagnostics
2.16.1 Ortho-Clinical Diagnostics Details
2.16.2 Ortho-Clinical Diagnostics Major Business
2.16.3 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
2.16.4 Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Ortho-Clinical Diagnostics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Point-of-Care Infectious Disease Diagnostics & Testing Players Market Share
3.2.2 Top 10 Point-of-Care Infectious Disease Diagnostics & Testing Players Market Share
3.2.3 Market Competition Trend
3.3 Point-of-Care Infectious Disease Diagnostics & Testing Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue and Market Share by Type (2016-2021)
4.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Application (2016-2021)
5.2 Point-of-Care Infectious Disease Diagnostics & Testing Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Type (2016-2026)
6.2 North America Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Application (2016-2026)
6.3 North America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country
6.3.1 North America Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Country (2016-2026)
6.3.2 United States Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2016-2026)
6.3.3 Canada Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2016-2026)
6.3.4 Mexico Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Type (2016-2026)
7.2 Europe Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Application (2016-2026)
7.3 Europe Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country
7.3.1 Europe Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Country (2016-2026)
7.3.2 Germany Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2016-2026)
7.3.3 France Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2016-2026)
7.3.5 Russia Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2016-2026)
7.3.6 Italy Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Type (2016-2026)
8.2 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Application (2016-2026)
8.3 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Region
8.3.1 Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Region (2016-2026)
8.3.2 China Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2016-2026)
8.3.3 Japan Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2016-2026)
8.3.4 South Korea Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2016-2026)
8.3.5 India Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2016-2026)
8.3.7 Australia Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Type (2016-2026)
9.2 South America Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Application (2016-2026)
9.3 South America Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country
9.3.1 South America Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Country (2016-2026)
9.3.2 Brazil Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2016-2026)
9.3.3 Argentina Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Type (2016-2026)
10.2 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Application (2016-2026)
10.3 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Market Size by Country
10.3.1 Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Country (2016-2026)
10.3.2 Turkey Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2016-2026)
10.3.4 UAE Point-of-Care Infectious Disease Diagnostics & Testing Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Point-of-Care Infectious Disease Diagnostics & Testing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million) by Region (2016-2021)
Table 5. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Region (2021-2026)
Table 6. Abbott Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Major Business
Table 8. Abbott Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 9. Abbott Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Thermo Fisher Scientific Inc Corporate Information, Head Office, and Major Competitors
Table 11. Thermo Fisher Scientific Inc Major Business
Table 12. Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 13. Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Roche Corporate Information, Head Office, and Major Competitors
Table 15. Roche Major Business
Table 16. Roche Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 17. Roche Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Siemens Healthineers Corporate Information, Head Office, and Major Competitors
Table 19. Siemens Healthineers Major Business
Table 20. Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 21. Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. BD & Company Corporate Information, Head Office, and Major Competitors
Table 23. BD & Company Major Business
Table 24. BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 25. BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Chembio Diagnostics Inc. Corporate Information, Head Office, and Major Competitors
Table 27. Chembio Diagnostics Inc. Major Business
Table 28. Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 29. Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Trinity Biotech Corporate Information, Head Office, and Major Competitors
Table 31. Trinity Biotech Major Business
Table 32. Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 33. Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Cardinal Health Corporate Information, Head Office, and Major Competitors
Table 35. Cardinal Health Major Business
Table 36. Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 37. Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Quest Diagnostics Inc. Corporate Information, Head Office, and Major Competitors
Table 39. Quest Diagnostics Inc. Major Business
Table 40. Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 41. Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Bio-Rad Labs Inc. Corporate Information, Head Office, and Major Competitors
Table 43. Bio-Rad Labs Inc. Major Business
Table 44. Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 45. Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. bioMérieux SA Corporate Information, Head Office, and Major Competitors
Table 47. bioMérieux SA Major Business
Table 48. bioMérieux SA Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 49. bioMérieux SA Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Sight Diagnostics Ltd. Corporate Information, Head Office, and Major Competitors
Table 51. Sight Diagnostics Ltd. Major Business
Table 52. Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 53. Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Gene POC Corporate Information, Head Office, and Major Competitors
Table 55. Gene POC Major Business
Table 56. Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 57. Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Trivitron Healthcare Corporate Information, Head Office, and Major Competitors
Table 59. Trivitron Healthcare Major Business
Table 60. Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 61. Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. OJ-Bio Ltd. Corporate Information, Head Office, and Major Competitors
Table 63. OJ-Bio Ltd. Major Business
Table 64. OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 65. OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Ortho-Clinical Diagnostics Corporate Information, Head Office, and Major Competitors
Table 67. Ortho-Clinical Diagnostics Major Business
Table 68. Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Product and Solutions
Table 69. Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million) by Players (2019-2021)
Table 71. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Share by Players (2019-2021)
Table 72. Breakdown of Point-of-Care Infectious Disease Diagnostics & Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 73. Point-of-Care Infectious Disease Diagnostics & Testing Players Head Office, Products and Services Provided
Table 74. Point-of-Care Infectious Disease Diagnostics & Testing Mergers & Acquisitions in the Past Five Years
Table 75. Point-of-Care Infectious Disease Diagnostics & Testing New Entrants and Expansion Plans
Table 76. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million) by Type (2016-2021)
Table 77. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Share by Type (2016-2021)
Table 78. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Forecast by Type (2021-2026)
Table 79. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Application (2016-2021)
Table 80. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Forecast by Application (2021-2026)
Table 81. North America Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Type (2016-2021) & (USD Million)
Table 82. North America Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Type (2021-2026) & (USD Million)
Table 83. North America Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Application (2016-2021) & (USD Million)
Table 84. North America Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Application (2021-2026) & (USD Million)
Table 85. North America Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Country (2016-2021) & (USD Million)
Table 86. North America Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Country (2021-2026) & (USD Million)
Table 87. Europe Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Type (2016-2021) & (USD Million)
Table 88. Europe Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Type (2021-2026) & (USD Million)
Table 89. Europe Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Application (2016-2021) & (USD Million)
Table 90. Europe Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Application (2021-2026) & (USD Million)
Table 91. Europe Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Country (2016-2021) & (USD Million)
Table 92. Europe Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Country (2021-2026) & (USD Million)
Table 93. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Type (2016-2021) & (USD Million)
Table 94. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Type (2021-2026) & (USD Million)
Table 95. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Application (2016-2021) & (USD Million)
Table 96. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Application (2021-2026) & (USD Million)
Table 97. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Region (2016-2021) & (USD Million)
Table 98. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Region (2021-2026) & (USD Million)
Table 99. South America Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Type (2016-2021) & (USD Million)
Table 100. South America Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Type (2021-2026) & (USD Million)
Table 101. South America Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Application (2016-2021) & (USD Million)
Table 102. South America Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Application (2021-2026) & (USD Million)
Table 103. South America Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Country (2016-2021) & (USD Million)
Table 104. South America Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Country (2021-2026) & (USD Million)
Table 105. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Type (2016-2021) & (USD Million)
Table 106. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Type (2021-2026) & (USD Million)
Table 107. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Application (2016-2021) & (USD Million)
Table 108. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Application (2021-2026) & (USD Million)
Table 109. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Country (2016-2021) & (USD Million)
Table 110. Middle East & Africa Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Point-of-Care Infectious Disease Diagnostics & Testing Picture
Figure 2. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Type in 2020
Figure 3. HIV POC
Figure 4. Clostridium difficile POC
Figure 5. HBV POC
Figure 6. Pneumonia or Streptococcus associated infections
Figure 7. Respiratory syncytial virus (RSV) POC
Figure 8. HPV POC
Figure 9. Influenza/Flu POC
Figure 10. Other Infectious Disease POC
Figure 11. Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Application in 2020
Figure 12. Hospitals Picture
Figure 13. Clinics Picture
Figure 14. Home Picture
Figure 15. Assisted Living Healthcare Facilities Picture
Figure 16. Laboratories Picture
Figure 17. Others Picture
Figure 18. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 19. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue and Forecast (2016-2026) & (USD Million)
Figure 20. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Region (2016-2026)
Figure 21. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Region in 2020
Figure 22. North America Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. Europe Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 24. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 25. South America Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 26. Middle East and Africa Point-of-Care Infectious Disease Diagnostics & Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 27. Point-of-Care Infectious Disease Diagnostics & Testing Market Drivers
Figure 28. Point-of-Care Infectious Disease Diagnostics & Testing Market Restraints
Figure 29. Point-of-Care Infectious Disease Diagnostics & Testing Market Trends
Figure 30. Abbott Recent Developments and Future Plans
Figure 31. Thermo Fisher Scientific Inc Recent Developments and Future Plans
Figure 32. Roche Recent Developments and Future Plans
Figure 33. Siemens Healthineers Recent Developments and Future Plans
Figure 34. BD & Company Recent Developments and Future Plans
Figure 35. Chembio Diagnostics Inc. Recent Developments and Future Plans
Figure 36. Trinity Biotech Recent Developments and Future Plans
Figure 37. Cardinal Health Recent Developments and Future Plans
Figure 38. Quest Diagnostics Inc. Recent Developments and Future Plans
Figure 39. Bio-Rad Labs Inc. Recent Developments and Future Plans
Figure 40. bioMérieux SA Recent Developments and Future Plans
Figure 41. Sight Diagnostics Ltd. Recent Developments and Future Plans
Figure 42. Gene POC Recent Developments and Future Plans
Figure 43. Trivitron Healthcare Recent Developments and Future Plans
Figure 44. OJ-Bio Ltd. Recent Developments and Future Plans
Figure 45. Ortho-Clinical Diagnostics Recent Developments and Future Plans
Figure 46. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Share by Players in 2020
Figure 47. Point-of-Care Infectious Disease Diagnostics & Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 48. Global Top 3 Players Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share in 2020
Figure 49. Global Top 10 Players Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share in 2020
Figure 50. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 51. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Share by Type in 2020
Figure 52. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Share Forecast by Type (2021-2026)
Figure 53. Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue Share by Application in 2020
Figure 54. Global Point-of-Care Infectious Disease Diagnostics & Testing Market Share Forecast by Application (2021-2026)
Figure 55. North America Point-of-Care Infectious Disease Diagnostics & Testing Sales Market Share by Type (2016-2026)
Figure 56. North America Point-of-Care Infectious Disease Diagnostics & Testing Sales Market Share by Application (2016-2026)
Figure 57. North America Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Country (2016-2026)
Figure 58. United States Point-of-Care Infectious Disease Diagnostics & Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Canada Point-of-Care Infectious Disease Diagnostics & Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Mexico Point-of-Care Infectious Disease Diagnostics & Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Europe Point-of-Care Infectious Disease Diagnostics & Testing Sales Market Share by Type (2016-2026)
Figure 62. Europe Point-of-Care Infectious Disease Diagnostics & Testing Sales Market Share by Application (2016-2026)
Figure 63. Europe Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Country (2016-2026)
Figure 64. Germany Point-of-Care Infectious Disease Diagnostics & Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. France Point-of-Care Infectious Disease Diagnostics & Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. United Kingdom Point-of-Care Infectious Disease Diagnostics & Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Russia Point-of-Care Infectious Disease Diagnostics & Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Italy Point-of-Care Infectious Disease Diagnostics & Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Sales Market Share by Type (2016-2026)
Figure 70. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Sales Market Share by Application (2016-2026)
Figure 71. Asia-Pacific Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Region (2016-2026)
Figure 72. China Point-of-Care Infectious Disease Diagnostics & Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Japan Point-of-Care Infectious Disease Diagnostics & Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South Korea Point-of-Care Infectious Disease Diagnostics & Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. India Point-of-Care Infectious Disease Diagnostics & Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Southeast Asia Point-of-Care Infectious Disease Diagnostics & Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Australia Point-of-Care Infectious Disease Diagnostics & Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South America Point-of-Care Infectious Disease Diagnostics & Testing Sales Market Share by Type (2016-2026)
Figure 79. South America Point-of-Care Infectious Disease Diagnostics & Testing Sales Market Share by Application (2016-2026)
Figure 80. South America Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Country (2016-2026)
Figure 81. Brazil Point-of-Care Infectious Disease Diagnostics & Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Argentina Point-of-Care Infectious Disease Diagnostics & Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. Middle East and Africa Point-of-Care Infectious Disease Diagnostics & Testing Sales Market Share by Type (2016-2026)
Figure 84. Middle East and Africa Point-of-Care Infectious Disease Diagnostics & Testing Sales Market Share by Application (2016-2026)
Figure 85. Middle East and Africa Point-of-Care Infectious Disease Diagnostics & Testing Revenue Market Share by Country (2016-2026)
Figure 86. Turkey Point-of-Care Infectious Disease Diagnostics & Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 87. Saudi Arabia Point-of-Care Infectious Disease Diagnostics & Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 88. UAE Point-of-Care Infectious Disease Diagnostics & Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 89. Methodology
Figure 90. Research Process and Data Source
世界の感染症ポイントオブケア診断市場 2021：企業別、地域別、種類・用途別 The Infectious Disease Point of Care Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…- 世界のポイントオブケア感染症市場 2021：企業別、地域別、種類・用途別 The Point of Care Infectious Disease market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 世界のB型肝炎感染症検査市場 2021：企業別、地域別、種類・用途別 The Hepatitis B Infectious Disease Tests market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- ポイントオブケア（POC）分子診断の世界市場… Scope of the Report: The global Point-of-Care Molecular Diagnostics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially…
- 獣医感染症診断の世界市場 2019年版：種類別（免疫診断、分子診断、その他の技術）、用途別（ラボ、病院、クリニック、その他） Scope of the Report: The global Veterinary Infectious Disease Diagnostics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, espe…